1. β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Roberts LD, Boström P, O'Sullivan JF, Schinzel RT, Lewis GD, Dejam A, Lee YK, Palma MJ, Calhoun S, Georgiadi A, Chen MH, Ramachandran VS, Larson MG, Bouchard C, Rankinen T, Souza AL, Clish CB, Wang TJ, Estall JL, Soukas AA, Cowan CA, Spiegelman BM, Gerszten RE (2014) Cell Metab 19(1): 96-108
    › Primary publication · 24411942 (PubMed) · PMC4017355 (PubMed Central)
  2. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Mahmood SS, Levy D, Vasan RS, Wang TJ (2014) Lancet 383(9921): 999-1008
    › Primary publication · 24084292 (PubMed) · PMC4159698 (PubMed Central)
  3. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation. Rienstra M, Yin X, Larson MG, Fontes JD, Magnani JW, McManus DD, McCabe EL, Coglianese EE, Amponsah M, Ho JE, Januzzi JL, Wollert KC, Fradley MG, Vasan RS, Ellinor PT, Wang TJ, Benjamin EJ (2014) Am Heart J 167(1): 109-115.e2
    › Primary publication · 24332149 (PubMed) · PMC3884900 (PubMed Central)
  4. Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, D'Agostino RB, Lee DS, Kannel WB, Benjamin EJ, Vasan RS (2014) Am J Cardiol 113(1): 117-22
    › Primary publication · 24210333 (PubMed) · PMC3881171 (PubMed Central)
  5. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure. Gaggin HK, Szymonifka J, Bhardwaj A, Belcher A, De Berardinis B, Motiwala S, Wang TJ, Januzzi JL (2014) JACC Heart Fail 2(1): 65-72
    › Primary publication · 24622120 (PubMed)
  6. Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program. Walford GA, Ma Y, Christophi CA, Goldberg RB, Jarolim P, Horton E, Mather KJ, Barrett-Connor E, Davis J, Florez JC, Wang TJ, Diabetes Prevention Program Research Group (2014) Diabetologia 57(5): 935-9
    › Primary publication · 24554005 (PubMed) · PMC4158711 (PubMed Central)
  7. The epidemiology of congestive heart failure: the Framingham Heart Study perspective. Mahmood SS, Wang TJ (2013) Glob Heart 8(1): 77-82
    › Primary publication · 23998000 (PubMed) · PMC3756692 (PubMed Central)
  8. Soluble ST2 predicts elevated SBP in the community. Ho JE, Larson MG, Ghorbani A, Cheng S, Vasan RS, Wang TJ, Januzzi JL (2013) J Hypertens 31(7): 1431-6; discussion 1436
    › Primary publication · 23615326 (PubMed) · PMC3986262 (PubMed Central)
  9. Risk assessment for incident heart failure in individuals with atrial fibrillation. Schnabel RB, Rienstra M, Sullivan LM, Sun JX, Moser CB, Levy D, Pencina MJ, Fontes JD, Magnani JW, McManus DD, Lubitz SA, Tadros TM, Wang TJ, Ellinor PT, Vasan RS, Benjamin EJ (2013) Eur J Heart Fail 15(8): 843-9
    › Primary publication · 23594831 (PubMed) · PMC3858114 (PubMed Central)
  10. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Schnabel RB, Yin X, Larson MG, Yamamoto JF, Fontes JD, Kathiresan S, Rong J, Levy D, Keaney JF, Wang TJ, Murabito JM, Vasan RS, Benjamin EJ (2013) Arterioscler Thromb Vasc Biol 33(7): 1728-33
    › Primary publication · 23640499 (PubMed) · PMC3753537 (PubMed Central)